ims-health-us documents

Oncologics Spending Reached $43.4 billion in 2014
Healthcare Oncologics Spending Reached $43.4 billion in 2014
Lessons in Specialty Data Integration: Best Practices for Small and Emerging Biopharma Companies
Healthcare Lessons in Specialty Data Integration: Best Practices for Small and Emerging Biopharma Companies
Mobile Micromarketing: Driving Performance from Strategy through Execution
Healthcare Mobile Micromarketing: Driving Performance from Strategy through Execution
Top Therapeutic Classes by Non-Discounted Spending
Healthcare Top Therapeutic Classes by Non-Discounted Spending
Transformations in Disease Treatment
Healthcare Transformations in Disease Treatment
Specialty Nedicines Now Account for One-third of Spending Driven by a Wave of Recent Innovations
Healthcare Specialty Nedicines Now Account for One-third of Spending Driven by a Wave of Recent Innovations
Medicines Use and Spending Shifts: A Review of the Use of Medicines
Healthcare Medicines Use and Spending Shifts: A Review of the Use of Medicines
Specialty Drugs for Hepatitis C, Multiple Sclerosis and Cancer Drove New Brand Spending Growth
Healthcare Specialty Drugs for Hepatitis C, Multiple Sclerosis and Cancer Drove New Brand Spending Growth
Specialty Medicines Now Account for One-third of Spending
Healthcare Specialty Medicines Now Account for One-third of Spending
Increasing Numbers of Launches and Growth in Spending on Specialty Products in 2014
Healthcare Increasing Numbers of Launches and Growth in Spending on Specialty Products in 2014
Oncology Market Dynamics
Healthcare Oncology Market Dynamics